Brief: Genprex Receives Notice Of Patent Grant For Korean Patent Claiming Reqorsa® Immunogene Therapy With Pd-1 And Pd-L1 Antibodies To Treat Cancers
March 12 (Reuters) - Genprex Inc GNPX.O :
* GENPREX RECEIVES NOTICE OF PATENT GRANT FOR KOREAN PATENT
CLAIMING REQORSA® IMMUNOGENE THERAPY WITH PD-1 AND PD-L1
ANTIBODIES TO TREAT CANCERS
Source text for Eikon: ID:nPn4dpspHa
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy